Methadon Neuraxpharm (Methadone Hydrochloride)

Methadone Hydrochloride is used in opioid‑related pathways to control dependence and provide analgesia.

• Opioid dependence: maintenance therapy reduces withdrawal symptoms and cravings.
• Severe chronic pain: provides long‑acting analgesic effect for patients requiring opioid treatment.
• Opioid detoxification: facilitates a controlled tapering process during supervised withdrawal programs.

• Methadone Hydrochloride acts as a full agonist at the mu‑opioid receptors in the central nervous system, producing analgesia and suppressing withdrawal by mimicking endogenous opioids. Its high oral bioavailability and long half‑life allow stable plasma concentrations, reducing the need for frequent dosing. The drug also exhibits NMDA receptor antagonism, which may contribute to its efficacy in chronic pain and opioid substitution therapy.

Methadone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: feeling of sickness.
• Sweating: excessive perspiration.
• Drowsiness: increased sleepiness.
• Dry mouth: reduced salivation.
• Dizziness: light‑headed sensation.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that can be life‑threatening.
• QT interval prolongation: cardiac rhythm disturbance increasing arrhythmia risk.
• Severe hypotension: marked drop in blood pressure.
• Adrenal insufficiency: inadequate cortisol production.
• Seizures: uncontrolled electrical activity in the brain.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing methadone, clinicians should observe several safety measures to minimize risk.

• Cardiac assessment: evaluate QT interval and history of arrhythmias.
• Respiratory monitoring: observe breathing, especially during initiation or dose changes.
• Liver function: check hepatic enzymes as methadone is metabolized hepatically.
• Gradual tapering: avoid abrupt discontinuation to prevent withdrawal.
• Renal impairment: adjust dosing and monitor accumulation.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Methadone interacts with several drug classes; awareness of these relationships helps prevent adverse events.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, alcohol): may cause profound respiratory depression.
• MAO inhibitors: increase risk of serotonin syndrome and hypertensive crisis.
• QT‑prolonging agents (e.g., haloperidol, sotalol): can exacerbate cardiac rhythm disturbances.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): raise methadone plasma levels.
• CYP3A4 inducers (e.g., rifampin, carbamazepine): lower methadone concentrations.
• Selective serotonin reuptake inhibitors: may increase risk of serotonin syndrome.
• Antihistamines and anticholinergics: can enhance sedation and anticholinergic effects.
• NSAIDs: may increase risk of gastrointestinal bleeding when combined with methadone‑induced constipation.